Antares Pharma CEO Robert Apple's 2019 pay rises 2% to $3.5M

Antares Pharma reports 2019 executive compensation

By ExecPay News

Published: April 27, 2020

Antares Pharma reported fiscal year 2019 executive compensation information on April 27, 2020.
In 2019, four executives at Antares Pharma received on average a compensation package of $1.8M, a 11% increase compared to previous year.
Average pay of disclosed executives at Antares Pharma
Robert F. Apple, Chief Executive Officer, received $3.5M in total, which increased by 2% compared to 2018. 47% of Apple's compensation, or $1.7M, was in stock awards. Apple also received $427K in non-equity incentive plan, $850K in option awards, $572K in salary, as well as $14K in other compensation.
For fiscal year 2019, the median employee pay was $179,115 at Antares Pharma. Therefore, the ratio of Robert F. Apple's pay to the median employee pay was 20 to one.
Fred M. Powell, Chief Financial Officer, received a compensation package of $1.4M, which increased by 5% compared to previous year. 38% of the compensation package, or $528K, was in stock awards.
Peter J. Graham, General Counsel, earned $1.4M in 2019, a 1% increase compared to previous year.
James P. Tursi, Chief Medical Officer, received $1.1M in 2019, which increases by 118% compared to 2018.

Related executives

Robert Apple

Antares Pharma

Chief Executive Officer

Fred Powell

Antares Pharma

Chief Financial Officer

Peter Graham

Antares Pharma

General Counsel

James Tursi

Antares Pharma

Chief Medical Officer

You may also like

Source: SEC filing on April 27, 2020.